A carregar...
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
OBJECTIVE: Initial success with chimeric antigen receptor–modified T cell therapy for relapsed/refractory acute lymphoblastic leukemia is leading to expanded use through multicenter trials. Cytokine release syndrome, the most severe toxicity, presents a novel critical illness syndrome with limited d...
Na minha lista:
Publicado no: | Crit Care Med |
---|---|
Main Authors: | , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5452983/ https://ncbi.nlm.nih.gov/pubmed/27632680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCM.0000000000002053 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|